Samsung hints at new products as it bets on AI to drive upgrades to its latest foldable phones
Samsung Electronics’ mobile boss TM Roh discussed Galaxy AI and software strategy, while hinting at future foldable products and mixed reality headsets.
How to invest in gold — and is it worth it?
From bars of bullion to ETFs, there’s plenty of ways to invest in gold. CNBC Pro takes a look at the pros and cons of each — and the potential risks involved.
Stocks soar, Dow closes 650 points higher buoyed by bullish inflation report: Live updates
The three major averages climbed on Friday.
These stocks have strong balance sheets as broader market sells off
Wolfe Research shared its latest list of stocks with high free cash flow.
Lineage closes up more than 3% in market’s largest IPO of 2024
Lineage, the largest temperature-controlled warehouse REIT in the world, closed up by more than 3% after going public under the ticker symbol “LINE.”
‘Deadpool & Wolverine’ set for highest opening of an R-rated film
Disney and Marvel’s “Deadpool & Wolverine” is expected to shatter box office records and become the highest opening film with an R-rating.
CNBC’s Inside India newsletter: The tax with potential side effects
The Indian government is borrowing a page from 17th-century England over taxation, but modern Britain holds the clue to some of its side effects.
CNBC’s Inside India newsletter: The tax with potential side effects
The Indian government is borrowing a page from 17th-century England over taxation, but modern Britain holds the clue to some of its side effects.
Wegovy rival to be part of a suite of weight loss drugs, Roche CEO says following positive trial results
Roche said Thursday that its Wegovy rival weight loss drugs will be part of a suite of medicines aimed at combatting the effects of obesity.
China to use ultra-long bonds for consumer, trade-in policy support as worries about retail sales slump grow
China on Thursday announced its most targeted measures yet for boosting consumption, which has remained lackluster since the pandemic.
